See the DrugPatentWatch profile for Methocarbamol
Methocarbamol is metabolized in the liver into inactive metabolites that are then excreted by the kidneys [1]. The primary pathway involves glucuronidation and sulfation, leading to the formation of metabolites such as the carbamate glucuronide and the phenolic glucuronide [2].
How is Methocarbamol broken down in the body?
Methocarbamol undergoes extensive hepatic metabolism [1]. The drug is primarily deactivated through conjugation reactions, primarily glucuronidation and sulfation, in the liver [2]. These processes attach molecules like glucuronic acid or sulfate to methocarbamol or its breakdown products, making them more water-soluble and easier for the body to eliminate [2].
What are the main inactive metabolites of Methocarbamol?
The main inactive metabolites of methocarbamol include its carbamate glucuronide and phenolic glucuronide conjugates [2]. These are formed after the initial breakdown of methocarbamol.
How is Methocarbamol removed from the body?
Following metabolism in the liver, the inactive metabolites of methocarbamol are eliminated from the body through the kidneys in the urine [1]. The increased water solubility due to glucuronidation and sulfation facilitates this renal excretion.
Are there any active metabolites of Methocarbamol?
While methocarbamol is extensively metabolized, the primary metabolic products are considered inactive [1][2]. There is no significant clinical activity attributed to these metabolites.
What is the role of the liver and kidneys in Methocarbamol elimination?
The liver is the central organ for methocarbamol metabolism, converting the parent drug into inactive metabolites. The kidneys then play the crucial role of excreting these metabolites from the body via urine [1][2].
What happens if someone has kidney or liver problems and takes Methocarbamol?
Impaired kidney or liver function can affect how the body processes and eliminates methocarbamol and its metabolites [3]. Individuals with such conditions may experience higher drug levels or a prolonged duration of action, potentially increasing the risk of adverse effects. Dosage adjustments may be necessary in these patient populations.
Can drug interactions affect Methocarbamol metabolism?
Yes, certain drug interactions can influence the metabolism of methocarbamol [3]. Drugs that affect liver enzyme activity, particularly those involved in glucuronidation or sulfation, could potentially alter methocarbamol levels in the body.
Sources:
1. Methocarbamol. DrugBank. https://go.drugbank.com/drugs/DB00526
2. Harvey SC. Muscle Relaxants. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics. 13th ed. McGraw Hill; 2018.
3. Methocarbamol. LiverTox: Clinical and Toxicological Database. National Institute of Diabetes and Digestive and Kidney Diseases. https://livertox.nih.gov/Methocarbamol.html